RESHAPING PROTEIN THERAPEUTICS Trademark Information

Adnexus, a Bristol-Myers Squibb R&D Company

Biotechnology and pharmaceutical products, namely, therapeutic proteins for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations for human use, namely,...

Biotechnology research and consultation services

This is a brand page for the RESHAPING PROTEIN THERAPEUTICS trademark by Adnexus, a Bristol-Myers Squibb R&D Company  in WALTHAM, MA, 02453.

Write a review about a product or service associated with this RESHAPING PROTEIN THERAPEUTICS trademark. Or, contact the owner Adnexus, a Bristol-Myers Squibb R&D Company of the RESHAPING PROTEIN THERAPEUTICS trademark by filing a request to communicate with the Legal Correspondent for licensing, use, and/or questions related to the RESHAPING PROTEIN THERAPEUTICS trademark.

On Friday, April 27, 2007, a U.S. federal trademark registration was filed for RESHAPING PROTEIN THERAPEUTICS. The USPTO has given the RESHAPING PROTEIN THERAPEUTICS trademark serial number of 77167585. The current federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED. The correspondent listed for RESHAPING PROTEIN THERAPEUTICS is Marilyn F. Kelly of Bristol-Myers Squibb Company, Trademark Department, 345 Park Avenue New York NY 10154 . The RESHAPING PROTEIN THERAPEUTICS trademark is filed in the category of Pharmaceutical Products , Computer & Software Services & Scientific Services . The description provided to the USPTO for RESHAPING PROTEIN THERAPEUTICS is Biotechnology and pharmaceutical products, namely, therapeutic proteins for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants and pharmaceutical antibodies.

Word mark: RESHAPING PROTEIN THERAPEUTICS
Status/Status Date:
ABANDONED - NO STATEMENT OF USE FILED
1/30/2012
Serial Number: 77167585
Filing Date: 4/27/2007
Registration Number: NOT AVAILABLE
Registration Date: NOT AVAILABLE
Goods and Services: Biotechnology and pharmaceutical products, namely, therapeutic proteins for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants and pharmaceutical antibodies
Mark Description: NOT AVAILABLE
Type Of Mark: Service Mark
Published For Opposition Date: 10/7/2008
Last Applicant/Owner: Adnexus, a Bristol-Myers Squibb R&D Company
WALTHAM, MA 02453
Mark Drawing Code: Standard Character Mark
Design Search: (NO DATA)
Register Type: Principal
Disclaimer: ("PROTEIN THERAPEUTICS")
Correspondent:
Bristol-Myers Squibb Company
Trademark Department
345 Park Avenue
New York NY 10154

Classification Information

Intent to Use Trademark - Applicant has not submitted proof of use in commerce the the USPTO.

Primary Class: Class Details:
Class (005)
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
First Use Anywhere: : Not provided
First Use In Commerce: Not provided
Class (042)
Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
First Use Anywhere: : Not provided
First Use In Commerce: Not provided

Trademarkia is the largest search engine for U.S. trademarks. Each month hundreds of trademarks around the world are filed by licensed attorneys in the Trademarkia Network Law firms! You can register your trademark in 170+ countries in the world through Trademarkia Network Law firms.

Trademarkia-Network law firms can help you incorporate a business around your RESHAPING PROTEIN THERAPEUTICS trademark in less than 5 minutes. Trademarkia makes the process easy and convenient, so start now!

Trademarkia.com is a free search engine of publicly available government records. Trademarkia.com is not a law firm and does not represent owners & correspondents listed on this page.

Trademark Document Retrieval >>

100% Satisfaction Guarantee protect your valuable brand now.

  • 1. Trademarkia Network law firm - #1 U.S. Trademark Filing from 2010 to now.
  • 2. Describe how your business or product is being used. Register your mark in 176+ countries. Starting $399/class + govt fees! Click here >>
  • 1. Top Global Specialist - Credibility and Experience!
  • 2. All processes will be performed in a timely manner.
Current Trademark Status:
1/30/2012
ABANDONED - NO STATEMENT OF USE FILED
Correspondent Search:

Marilyn F. Kelly is a correspondent of RESHAPING PROTEIN THERAPEUTICS trademark.

Current Overall Rating:
RatingRatingRatingRatingRating (0 review)
What You Can Do: